Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Singer

Showing results (31-40 of 110) with videos related to

Pageof 11
Sort By:
Vaccine|December 7, 2025
Real-world utilization and potential clinical and economic value of recombinant zoster vaccine and select preventive services recommended for older adults in the United StatesJustin Gatwood, Evelyn Gomez-Espinosa, Nicole Fusco, et al.
Neuropsychiatric Disease and Treatment|January 27, 2021
The Health-Related Quality of Life, Work Productivity, Healthcare Resource Utilization, and Economic Burden Associated with Levels of Suicidal Ideation Among Patients Self-Reporting Moderately Severe or Severe Major Depressive Disorder in a National SurveyCarmela Benson, David Singer, Colleen M Carpinella, et al.
Vaccine|February 27, 2025
Corrigendum to "The potential impact of increased recombinant zoster vaccine coverage on the burden of herpes zoster among adults aged 50-59 years" [Vaccine 41 (37) (23 August 2023) 5360-5367]David Singer, Ahmed Salem, Nikita Stempniewicz, et al.
Vaccine|August 4, 2023
The potential impact of increased recombinant zoster vaccine coverage on the burden of herpes zoster among adults aged 50-59 yearsDavid Singer, Ahmed Salem, Nikita Stempniewicz, et al.
Population Health Management|June 5, 2024
Knowledge, Attitudes, and Practices Regarding Herpes Zoster Vaccination Among SpecialistsDavid Singer, Carolyn Sweeney, Nikita Stempniewicz, et al.
Population Health Management|November 28, 2025
Disparities in Recombinant Zoster Vaccine Coverage in the United StatesDavid Singer, Nikita Stempniewicz, Lydia Lee, et al.
Annals of Plastic Surgery|April 16, 2004
An anatomic and histologic analysis of the alar-facial crease and the lateral crusJagruti C Patel, James W Fletcher, David Singer, et al.
Vaccines|September 8, 2015
Doubly Phosphorylated Peptide Vaccines to Protect Transgenic P301S Mice against Alzheimer's Disease Like Tau AggregationMonique Richter, Agneta Mewes, Manuela Fritsch, et al.
European Journal of Protistology|January 3, 2015
Eight species in the Nebela collaris complex: Nebela gimlii (Arcellinida, Hyalospheniidae), a new species described from a Swiss raised bogDavid Singer, Anush Kosakyan, Amandine Pillonel, et al.
Journal of Clinical Pharmacy and Therapeutics|March 16, 2019
Real-world evidence on adherence, persistence, switching and dose escalation with biologics in adult inflammatory bowel disease in the United States: A systematic reviewShahnaz Khan, Ewa Rupniewska, Mackenzie Neighbors, et al.
Pageof 11

Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
Vaccine|December 7, 2025
Real-world utilization and potential clinical and economic value of recombinant zoster vaccine and select preventive services recommended for older adults in the United StatesJustin Gatwood, Evelyn Gomez-Espinosa, Nicole Fusco, et al.
Neuropsychiatric Disease and Treatment|January 27, 2021
The Health-Related Quality of Life, Work Productivity, Healthcare Resource Utilization, and Economic Burden Associated with Levels of Suicidal Ideation Among Patients Self-Reporting Moderately Severe or Severe Major Depressive Disorder in a National SurveyCarmela Benson, David Singer, Colleen M Carpinella, et al.
Vaccine|February 27, 2025
Corrigendum to "The potential impact of increased recombinant zoster vaccine coverage on the burden of herpes zoster among adults aged 50-59 years" [Vaccine 41 (37) (23 August 2023) 5360-5367]David Singer, Ahmed Salem, Nikita Stempniewicz, et al.
Vaccine|August 4, 2023
The potential impact of increased recombinant zoster vaccine coverage on the burden of herpes zoster among adults aged 50-59 yearsDavid Singer, Ahmed Salem, Nikita Stempniewicz, et al.
Population Health Management|June 5, 2024
Knowledge, Attitudes, and Practices Regarding Herpes Zoster Vaccination Among SpecialistsDavid Singer, Carolyn Sweeney, Nikita Stempniewicz, et al.
Population Health Management|November 28, 2025
Disparities in Recombinant Zoster Vaccine Coverage in the United StatesDavid Singer, Nikita Stempniewicz, Lydia Lee, et al.
Annals of Plastic Surgery|April 16, 2004
An anatomic and histologic analysis of the alar-facial crease and the lateral crusJagruti C Patel, James W Fletcher, David Singer, et al.
Vaccines|September 8, 2015
Doubly Phosphorylated Peptide Vaccines to Protect Transgenic P301S Mice against Alzheimer's Disease Like Tau AggregationMonique Richter, Agneta Mewes, Manuela Fritsch, et al.
European Journal of Protistology|January 3, 2015
Eight species in the Nebela collaris complex: Nebela gimlii (Arcellinida, Hyalospheniidae), a new species described from a Swiss raised bogDavid Singer, Anush Kosakyan, Amandine Pillonel, et al.
Journal of Clinical Pharmacy and Therapeutics|March 16, 2019
Real-world evidence on adherence, persistence, switching and dose escalation with biologics in adult inflammatory bowel disease in the United States: A systematic reviewShahnaz Khan, Ewa Rupniewska, Mackenzie Neighbors, et al.
Pageof 11